• English
  • Korean
  • Chinese
表紙
市場調査レポート - 240774

世界の医療用バイオセンサー市場

Global Medical Biosensors Market 2014-2018

発行 Infiniti Research Limited (Technavio)
出版日 ページ情報 英文 92 Pages
電子版即納可
価格
世界の医療用バイオセンサー市場 Global Medical Biosensors Market 2014-2018
出版日: 2014年07月23日 ページ情報: 英文 92 Pages
概要

医療用バイオセンサーは、物理化学的な検知装置の力を借りて生体成分の動向を分析するものです。こうした装置は、侵襲的/費侵襲的な手法を用いて、患者の健康状態や疾患の改善状況、治療結果の状況などをモニタリングしています。これらはコスト効率的で取り使いもしやすく、かつ患者診断中に発生するエラーを最小限に留めるように標準化されています。主な用途としては、コレステロールや病原体の検知、筋肉の代替、脳脊髄の検知などが挙げられます。また、患者のQoL(生活の質)の向上に重要な役割を果たしています。世界の医療用バイオセンサー市場は、2013年から2018年にかけて、年平均成長率(CAGR)10.16%で拡大する見通しです。

当レポートでは、世界の医療用バイオセンサー市場の概要・構造や市場動向(今後5年間の予測値)、地域別の詳細動向、市場の促進・抑制要因とその影響力、主要企業のプロファイル、今後の市場機会などを調査・考察しております。

第1章 エグゼクティブ・サマリー

第2章 略語集

第3章 分析範囲

  • 市場概要
  • 主な製品

第4章 市場分析の手法

  • 市場分析のプロセス
  • 分析手法

第5章 イントロダクション

第6章 市場環境

  • 市場概況
  • 市場規模とその予測
  • ファイブフォース分析

第7章 用途別の詳細分析

  • 世界の血糖モニタリング市場
    • 市場規模とその予測
  • 世界のコレステロール・モニタリング市場
  • 世界の感染症検査市場
  • 世界の心臓バイオマーカー検査市場
  • 世界の血液ガス検査市場
  • 世界の妊娠検査市場

第8章 技術別の詳細分析

  • 電子化学バイオセンサー
  • 光学式バイオセンサー
  • 圧電方式バイオセンサー

第9章 エンドユーザー別の詳細分析

  • POC(ポイントオブケア)用検査装置市場
  • 家庭用診断装置市場
  • 研究開発用装置市場

第10章 地域別の分析

  • 南北アメリカの医療用バイオセンサー市場
  • 欧州・中東・アフリカ(EMEA)地域の医療用バイオセンサー市場
  • アジア太平洋(APAC)地域の医療用バイオセンサー市場

第11章 購入基準

第12章 市場発展要因

第13章 成長要因とその影響

第14章 市場課題

第15章 発展要因と課題の影響

第16章 市場傾向

第17章 市場動向とその影響

第18章 ベンダー環境

  • 競争シナリオ
    • 近年の主な動向
  • 市場シェア分析
  • その他の著名なベンダー
  • Abbott Laboratories
    • 事業概要
    • 事業構造
    • 部門別の売上高
    • 地域別の売上高
    • 主要データ
    • SWOT分析
  • Bayer HealthCare
  • LifeScan
  • F. Hoffmann-La Roche

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

About

Medical biosensors are used to analyze biological components with the help of physicochemical detectors. These biosensors monitor health status, disease betterment, and therapeutic treatment outcomes through invasive and non-invasive methods. They are cost-effective and user-friendly devices. Also, they are standardized to minimize errors during the diagnosis of patients. Medical biosensors are mostly used in cholesterol detection, pathogen detection, muscle displacement, and cerebrospinal detection. Medical biosensors play a major role in improving patients' quality of life.

TechNavio's analysts forecast the Global Medical Biosensors market to grow at a CAGR of 10.16 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Medical Biosensors market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of various medical biosensors, based on their application such as:

Blood glucose testing

Cholesterol testing

Infectious disease testing

Cardiac biomarkers testing

Blood gas testing

Pregnancy testing

Others (such as cancer biomarkers, electrolyte analyzers, blood coagulation testing, tumor markers, and urinalysis testing)

TechNavio's report, the Global Medical Biosensors market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Medical Biosensors Platform market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

Americas

EMEA

APAC

Key Vendors

Abbott Laboratories

Bayer HealthCare AG

LifeScan Inc.

F. Hoffmann-La Roche Ltd.

Other Prominent Vendors

Acethem

Acon

Biotest Medical

FICO

Contec Medical

Convergent

Integrity

I-sens

Nipro Diagnostics

Optiscan

TaiDoc

Urit Medical

Market Driver

Increase in Technological Innovations

For a full, detailed list, view our report

Market Challenge

Advances in Technology

For a full, detailed list, view our report

Market Trend

Expanding Economies in the APAC Region

For a full, detailed list, view our report

Key Questions Answered in this Report

What will the market size be in 2018 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1 Market Overview
  • 03.2 Product Offerings

04. Market Research Methodology

  • 04.1 Market Research Process
  • 04.2 Research Methodology

05. Introduction

06. Market Landscape

  • 06.1 Market Overview
  • 06.2 Market Size and Forecast
  • 06.3 Five Forces Analysis

07. Market Segmentation by Application

  • 07.1 Global Blood Glucose Testing Market
  • 07.1.1 Market Size and Forecast
  • 07.2 Global Cholesterol Testing Market
  • 07.2.1 Market Size and Forecast
  • 07.3 Global Infectious Disease Testing Market
  • 07.3.1 Market Size and Forecast
  • 07.4 Global Cardiac Biomarkers Testing Market
  • 07.4.1 Market Size and Forecast
  • 07.5 Global Blood Gas Testing Market
  • 07.5.1 Market Size and Forecast

Global Pregnancy Testing Market

  • 07.5.2 Market Size and Forecast

08. Market Segmentation by Technology

  • 08.1 Electrochemical Biosensors
  • 08.2 Optical Biosensors
  • 08.3 Piezoelectric Biosensors

09. Market Segmentation by End-user

  • 09.1 Global Point-of-Care Testing Market
  • 09.1.1 Market Size and Forecast
  • 09.2 Global Home Diagnostics Market
  • 09.2.1 Market Size and Forecast
  • 09.3 Global Research Laboratories Market
  • 09.3.1 Market Size and Forecast

10. Geographical Segmentation

  • 10.1 Medical Biosensors Market in the Americas
  • 10.1.1 Market Size and Forecast
  • 10.2 Medical Biosensors Market in the EMEA Region
  • 10.2.1 Market Size and Forecast
  • 10.3 Medical Biosensors Market in the APAC Region
  • 10.3.1 Market Size and Forecast

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

  • 18.1 Competitive Scenario
  • 18.1.1 Key News
  • 18.2 Market Share Analysis 2013
  • 18.3 Other Prominent Vendors
  • 18.4 Abbott Laboratories
  • 18.4.1 Key Facts
  • 18.4.2 Business Overview
  • 18.4.3 Business Segmentation by Revenue 2012
  • 18.4.4 Business Segmentation by Revenue 2011 and 2012
  • 18.4.5 Geographical Segmentation by Revenue 2012
  • 18.4.6 Business Strategy
  • 18.4.7 Key Information
  • 18.4.8 SWOT Analysis
  • 18.4.9 Strengths
  • 18.4.10 Weakness
  • 18.4.11 Opportunities
  • 18.4.12 Threats
  • 18.5 Bayer HealthCare
  • 18.5.1 Key Facts
  • 18.5.2 Business Overview
  • 18.5.3 Business Segmentation by Revenue 2013
  • 18.5.4 Business Segmentation by Revenue 2012 and 2013
  • 18.5.5 Geographical Segmentation by Revenue 2013
  • 18.5.6 Business Strategy
  • 18.5.7 Recent Developments
  • 18.5.8 SWOT Analysis
  • 18.5.9 Strengths
  • 18.5.10 Weaknesses
  • 18.5.11 Opportunities
  • 18.5.12 Threats
  • 18.6 LifeScan
  • 18.6.1 Key Facts
  • 18.6.2 Business Overview
  • 18.6.3 Product Segmentation
  • 18.6.4 Geographical Segmentation by Revenue 2013
  • 18.6.5 Business Strategy
  • 18.6.6 Recent Developments
  • 18.6.7 SWOT Analysis
  • 18.6.8 Strengths
  • 18.6.9 Weaknesses
  • 18.6.10 Opportunities
  • 18.6.11 Threats
  • 18.7 F. Hoffmann-La Roche
  • 18.7.1 Key Facts
  • 18.7.2 Business Overview
  • 18.7.3 Business Segmentation by Revenue 2013
  • 18.7.4 Business Segmentation by Revenue 2012 and 2013
  • 18.7.5 Geographical Segmentation by Revenue 2013
  • 18.7.6 Business Strategy
  • 18.7.7 Recent Developments
  • 18.7.8 SWOT Analysis
  • 18.7.9 Strengths
  • 18.7.10 Weaknesses
  • 18.7.11 Opportunities
  • 18.7.12 Threats

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Medical Biosensors Market 2013-2018 (US$ million)
  • Exhibit 3: Global Medical Biosensors Market Segmentation by Application
  • Exhibit 4: Global Medical Biosensors Segmentation Market by Application 2013
  • Exhibit 5: Global Blood Glucose Testing Market 2013-2018 (US$ million)
  • Exhibit 6: Global Cholesterol Testing Market 2013-2018 (US$ million)
  • Exhibit 7: Global Infectious Disease Testing Market 2013-2018 (US$ million)
  • Exhibit 8: Global Cardiac Biomarkers Testing Market 2013-2018 (US$ million)
  • Exhibit 9: Global Blood Gas Analyzers Market 2013-2018 (US$ million)
  • Exhibit 10: Global Pregnancy Testing Market 2013-2018 (US$ million)
  • Exhibit 11: Global Medical Biosensors Market Segmentation by Application 2013-2018
  • Exhibit 12: Global Medical Biosensors Market Segmentation by Application 2013-2018 (US$ million)
  • Exhibit 13: Global Medical Biosensors Market Segmentation by Technology
  • Exhibit 14: Global Medical Biosensors Market Segmentation by End-user
  • Exhibit 15: Global Medical Biosensors Market Segmentation by End-user 2013
  • Exhibit 16: Global Point-of-Care Testing Market 2013-2018 (US$ million)
  • Exhibit 17: Global Home Diagnostics Market 2013-2018 (US$ million)
  • Exhibit 18: Global Research Laboratories Market 2013-2018 (US$ million)
  • Exhibit 19: Global Medical Biosensors Market Segmentation by End-user 2013-2018
  • Exhibit 20: Global Medical Biosensors Market by Geographical Segmentation 2013
  • Exhibit 21: Global Medical Biosensors Market by Geographical Segmentation 2013-2018
  • Exhibit 22: Medical Biosensors Market in the Americas 2013-2018 (US$ million)
  • Exhibit 23: Medical Biosensors Market in the EMEA Region 2013-2018 (US$ million)
  • Exhibit 24: Medical Biosensors Market in the APAC Region 2013-2018 (US$ million)
  • Exhibit 25: Global Medical Biosensors Market Share Analysis 2013
  • Exhibit 26: Abbott Laboratories: Business Segmentation by Revenue 2012
  • Exhibit 27: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
  • Exhibit 28: Abbott Laboratories: Geographical Segmentation by Revenue 2012
  • Exhibit 29: Bayer HealthCare: Business Segmentation by Revenue 2013
  • Exhibit 30: Bayer HealthCare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 31: Bayer HealthCare: Geographical Segmentation by Revenue 2013
  • Exhibit 32: LifeScan: Product Segmentation 2013
  • Exhibit 33: LifeScan: Geographical Segmentation by Revenue 2013
  • Exhibit 34: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
  • Exhibit 35: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 36: F. Hoffmann-La Roche: Geographical Segmentation of Pharmaceuticals Division by Revenue 2013
  • Exhibit 37: F. Hoffmann-La Roche: Geographical Segmentation of Diagnostics Division by Revenue 2013
Back to Top